›› 2016, Vol. 36 ›› Issue (1): 77-80.

• 综述 • 上一篇    下一篇

Semaphorin 3A在肿瘤中的研究进展

朱零1,宋晓萌2   

  1. 1. 南京医科大学口腔疾病研究江苏省重点实验室,南京医科大学附属口腔医院
    2. 南京医科大学口腔医学院
  • 收稿日期:2015-07-15 修回日期:2015-08-03 出版日期:2016-01-28 发布日期:2016-01-08
  • 通讯作者: 宋晓萌 E-mail:sxm2081@163.com
  • 基金资助:
    国家自然科学基金;江苏高校优势学科建设工程资助项目

The research progress of Semaphorin 3A in cancer

ZHU Ling,   

  • Received:2015-07-15 Revised:2015-08-03 Online:2016-01-28 Published:2016-01-08

摘要: 神经导向因子与肿瘤的关系正受到越来越多的关注。Semaphorin 3A(SEMA 3A)是Semaphorins(SEMAs)家族成员中最早被研究的神经导向因子。进一步研究表明SEMA 3A在诱导凋亡、细胞迁移、肿瘤生长及免疫调控上也有重要作用。因此,SEMA 3A被认为是肿瘤治疗的新靶点。该文将以SEMA 3A在肿瘤中的“抑制作用”和“促进作用”为重点,对其结构、机制、作用和研究意义进行综述。

关键词: Semaphorin 3A, Neuropilin-1, plexin-A1, 肿瘤

Abstract: The relationship between neuronal guidance factor and tumor is getting more and more attention. Semaphorin 3A(SEMA 3A) is the first one that studied as neuronal guidance factor in the family of Semaphorins.With the further research,it is fined that SEMA 3A also plays an important role in apoptosis,cell migration,tumor growth and immunoregulation.Therefore,it is considered that SEMA 3A is a new breakthrough of oncotherapy.This article reviews current knowledge on structure and mechanism of SEMA 3A, as well as its research status,focusing in the its “Promotion effect” and “Inhibiting effect” in cancer.

Key words: Semaphorin 3A, Neuropilin-1, plexin-A1, cancer

中图分类号: